Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lechoslaw Turski

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Lancet. Neurology|July 10, 2003
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?Chrysanthy Ikonomidou, Lechoslaw Turski
Epilepsy Research|October 15, 2009
Antiepileptic drugs and brain developmentChrysanthy Ikonomidou, Lechoslaw Turski
Biochemical Pharmacology|September 18, 2002
Glutamate antagonists limit tumor growthWojciech Rzeski, Chrysanthy Ikonomidou, Lechoslaw Turski
Annals of the New York Academy of Sciences|July 11, 2003
Multiple sclerosis and glutamateAnthony J Groom, Terence Smith, Lechoslaw Turski
Restorative Neurology and Neuroscience|April 3, 2003
Tolerance to and Dependence on Alprazolam are Due to Changes in GABAa Receptor Function and Are Independent of Exposure to Experimental Set-upRuggero Galici, Graziano Pinna, David N. Stephens, et al.
Restorative Neurology and Neuroscience|June 30, 2020
AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectivesWaldemar A Turski, Artur Wnorowski, Gabrielle N Turski, et al.
Brain Pathology (Zurich, Switzerland)|October 11, 2007
Glutamate receptor expression in multiple sclerosis lesionsJia Newcombe, Alim Uddin, Rosamund Dove, et al.
Journal of Medicinal Chemistry|July 8, 2005
Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegenerationBernd Elger, Andreas Huth, Roland Neuhaus, et al.
Cancer Biology & Therapy|October 7, 2008
Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cellsAndrzej Stepulak, Wojciech Rzeski, Marco Sifringer, et al.
Cancer Biology & Therapy|December 7, 2007
AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growthAndrzej Stepulak, Marco Sifringer, Wojciech Rzeski, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Lancet. Neurology|July 10, 2003
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?Chrysanthy Ikonomidou, Lechoslaw Turski
Epilepsy Research|October 15, 2009
Antiepileptic drugs and brain developmentChrysanthy Ikonomidou, Lechoslaw Turski
Biochemical Pharmacology|September 18, 2002
Glutamate antagonists limit tumor growthWojciech Rzeski, Chrysanthy Ikonomidou, Lechoslaw Turski
Annals of the New York Academy of Sciences|July 11, 2003
Multiple sclerosis and glutamateAnthony J Groom, Terence Smith, Lechoslaw Turski
Restorative Neurology and Neuroscience|April 3, 2003
Tolerance to and Dependence on Alprazolam are Due to Changes in GABAa Receptor Function and Are Independent of Exposure to Experimental Set-upRuggero Galici, Graziano Pinna, David N. Stephens, et al.
Restorative Neurology and Neuroscience|June 30, 2020
AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectivesWaldemar A Turski, Artur Wnorowski, Gabrielle N Turski, et al.
Brain Pathology (Zurich, Switzerland)|October 11, 2007
Glutamate receptor expression in multiple sclerosis lesionsJia Newcombe, Alim Uddin, Rosamund Dove, et al.
Journal of Medicinal Chemistry|July 8, 2005
Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegenerationBernd Elger, Andreas Huth, Roland Neuhaus, et al.
Cancer Biology & Therapy|October 7, 2008
Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cellsAndrzej Stepulak, Wojciech Rzeski, Marco Sifringer, et al.
Cancer Biology & Therapy|December 7, 2007
AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growthAndrzej Stepulak, Marco Sifringer, Wojciech Rzeski, et al.
Pageof 2